Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
102 studies found for:    "glycogen storage disease type IX" OR "Glycogen Storage Disease"
Show Display Options
RSS Create an RSS feed from your search for:
"glycogen storage disease type IX" OR "Glycogen Storage Disease"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Study of Glycogen Storage Disease and Associated Disorders
Condition: Glycogen Storage Disease
Intervention:
2 Completed Study of Glycogen Storage Disease Expression in Carriers
Condition: Glycogen Storage Disease
Intervention: Genetic: Glycogen Storage Disease markers
3 Recruiting The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V)
Condition: Glycogen Storage Disease Type V
Interventions: Drug: Triheptanoin;   Other: Placebo oil
4 Recruiting Glycogen Storage Disease Type IV Database
Condition: Glycogen Storage Disease Type IV
Intervention: Other: No intervention
5 Terminated Clinical Evaluation of a Non-Invasive Hypoglycemia Detector in a Glycogen Storage Disease Population
Condition: Glycogen Storage Disease
Intervention: Device: Diabetes Sentry
6 Completed Overnight Feeding Study in Glycogen Storage Disease Type 1
Condition: Glycogen Storage Disease Type 1 (GSD 1)
Intervention: Other: overnight nutrition regime
7 Recruiting Glycosade v UCCS in the Dietary Management of Hepatic GSD
Condition: Glycogen Storage Disease
Intervention: Dietary Supplement: Medical Food - Glycosade
8 Completed
Has Results
Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Disease;   Glycogen Storage Disease Type Ia
Intervention: Other: Glycogen Storage Disease type Ia patients
9 Not yet recruiting Triheptanoin in Mc Ardle
Condition: Glycogen Storage Disease Type V
Interventions: Drug: Triheptanoin;   Drug: Placebo oil
10 Completed A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type II
Conditions: Glycogen Storage Disease Type II;   Pompe Disease;   Acid Maltase Deficiency Disease;   Glycogenosis 2
Intervention: Drug: Alglucosidase alfa
11 Completed Sleep and Quality of Life in Patients With Glycogen Storage Disease on Standard Versus Modified Uncooked Cornstarch
Conditions: Glycogen Storage Disease Type IA;   Glycogen Storage Disease Type IB;   Glycogen Storage Disease Type III;   Glycogen Storage Disease Type 0
Intervention: Dietary Supplement: Glycosade
12 Completed A Prospective, Observational Study in Patients With Late-Onset Pompe Disease
Condition: Glycogen Storage Disease Type II
Intervention:
13 Completed A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease
Condition: Glycogen Storage Disease Type II
Intervention: Biological: Myozyme
14 Completed Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602
Condition: Glycogen Storage Disease Type II
Intervention: Biological: Myozyme
15 Not yet recruiting Respiratory Muscle Training in LOPD
Condition: Glycogen Storage Disease Type II
Interventions: Device: RMT therapy using modified RMT device;   Device: Sham-RMT therapy using modified RMT device
16 Recruiting Effect of Motor Development, Motor Function and Electrophysiologic Findings of IOPD Under ERT
Condition: Glycogen Storage Disease Type II
Intervention: Other: observation study
17 Recruiting Energy Supplements to Improve Exercise Tolerance in Metabolic Myopathies
Condition: Glycogen Storage Disease Type III
Interventions: Dietary Supplement: FAXE Kondi;   Dietary Supplement: Faxe Kondi Free
18 Withdrawn High Protein and Exercise Therapy Plus Nocturnal Enteral Feeding in Juvenile-onset Pompe Disease
Condition: Glycogen Storage Disease Type II
Intervention: Other: High Protein and Exercise Therapy along-with Nocturnal Enteral Feeding
19 Completed Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies
Conditions: Pompe Disease Infantile-Onset;   Glycogen Storage Disease Type II
Intervention: Biological: Myozyme
20 Completed Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease
Conditions: Glycogen Storage Disease Type II;   Glycogenosis 2
Intervention: Biological: Myozyme

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.